Search

everythinglearnresearchcommunity

for

Search:↓

Some people may temporarily lose more hair in certain areas after a hair transplant.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

Low ferritin and zinc levels, as well as anemia, are linked to more severe hair loss in Egyptian children with chronic hair shedding.

Iron deficiency is linked to hair loss in CTE patients.

People with chronic hair loss may have a higher chance of Vitamin B12 deficiency.

A patient experienced intense hair loss due to telogen effluvium after scalp contact dermatitis, but hair regrew completely within two months without further treatment.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

COVID-19 may cause hair loss due to infection stress or treatments.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

A dietary supplement with Boswellia serrata, Curcuma longa, and Vitis vinifera showed potential improvement in hair health for telogen effluvium patients, but more research is needed.

One supplement improved hair loss and quality faster and more effectively than the other in treating telogen effluvium.

Hair loss in a woman with eosinophilia-myalgia syndrome improved after stopping L-tryptophan and starting treatment.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

Hair is thinner near the scalp in acute hair shedding conditions.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Hair loss causes stress and affects mental health; treatment and support needed.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

Two people lost a lot of hair because of epilepsy drugs, but their hair grew back after changing medication.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

Some people with chronic hair loss may have thyroid autoimmunity.